Massive hematemesis - Causes, Treatment & When to See a Doctor

What is Massive Hematemesis?

Massive hematemesis refers to the sudden, profuse vomiting of bright‑red or "coffee‑ground" blood that originates from the upper gastrointestinal (GI) tract. The term “massive” is used when the volume of blood exceeds 500 mL in a single episode or when rapid blood loss leads to hemodynamic instability (drop in blood pressure, rapid heart rate, faintness). This is a medical emergency because the rapid loss of blood can quickly progress to shock, organ failure, or death if not treated promptly.

Hematology experts define massive upper‑GI bleeding as any brisk arterial bleeding that requires immediate resuscitation and often endoscopic or surgical intervention [1]. The source may be a single lesion (e.g., a bleeding ulcer) or multiple sites (e.g., diffuse variceal disease). Because the blood is expelled through vomiting, patients can often see the blood directly, which can be terrifying and may delay the decision to seek care.

Common Causes

Although many conditions can cause upper‑GI bleeding, the following are the most frequent culprits of massive hematemesis:

• Peptic ulcer disease (PUD) – especially duodenal ulcers eroding a nearby artery.
• Esophageal or gastric varices – dilated veins from portal hypertension (commonly due to liver cirrhosis).
• Gastric erosions/acute gastritis – often precipitated by NSAIDs, alcohol, or stress.
• Esophageal tear (Mallory‑Weiss syndrome) – linear mucosal lacerations after severe retching.
• Esophageal or gastric cancer – tumor invasion into blood vessels.
• Aorto‑esophageal fistula – a rare but fatal connection between the aorta and esophagus, sometimes after thoracic aortic aneurysm repair.
• Dieulafoy lesion – an abnormally large submucosal artery that can rupture without a surrounding ulcer.
• Severe coagulopathy – (e.g., from liver failure, anticoagulant overdose, or disseminated intravascular coagulation) that predisposes to bleeding from otherwise minor lesions.
• Traumatic injury – penetrating or blunt trauma to the abdomen/pharynx causing mucosal disruption.
• Vasculitis of the GI tract – such as polyarteritis nodosa or systemic lupus erythematosus involvement.

Associated Symptoms

Massive hematemesis rarely occurs in isolation. Patients often experience one or more of the following alongside vomiting blood:

• Chest or upper‑abdominal pain (sharp, burning, or gnawing)
• Melena (black, tarry stools) indicating slower bleeding further down the GI tract
• Dizziness, light‑headedness, or fainting (syncope)
• Rapid, weak pulse (tachycardia) and low blood pressure (hypotension)
• Shortness of breath or feeling “air‑hungry” due to anemia
• Confusion or agitation (signs of hypoperfusion to the brain)
• Palpitations or feeling of a racing heart
• Fever or chills if the bleed is related to an infection (e.g., erosive gastritis from H. pylori)
• Abdominal distension or rigidity (suggesting perforation)

When to See a Doctor

Any amount of vomiting blood warrants medical attention, but the following situations make an urgent ED visit essential:

• Vomiting > 200 mL of blood in one episode or any amount that looks “coffee‑ground” (partially digested blood).
• Signs of shock: dizziness, fainting, cold/clammy skin, rapid breathing, or a pulse > 100 bpm.
• Persistent vomiting (more than one episode) or ongoing bleeding despite attempts to stop.
• History of liver disease, known varices, or anticoagulant use.
• Severe abdominal pain, especially if sudden and tearing.
• Neurologic changes: confusion, slurred speech, or loss of consciousness.
• Recent trauma to the chest/abdomen or recent endoscopic procedures.

Even if the bleeding stops, a follow‑up with a gastroenterologist is recommended because the underlying lesion often needs definitive treatment to prevent recurrence.

Diagnosis

In the emergency setting, doctors follow a systematic approach to identify the source, assess severity, and stabilize the patient.

Initial Assessment & Resuscitation

1. Airway, Breathing, Circulation (ABCs) – ensure the airway is clear (avoid aspiration), give supplemental O₂, and start IV fluids.
2. Vital signs monitoring – blood pressure, heart rate, respiratory rate, and oxygen saturation.
3. Large‑bore IV access – usually two 14‑ or 16‑gauge lines for rapid fluid/blood product infusion.
4. Laboratory tests – CBC (hemoglobin/hematocrit), coagulation profile (PT/INR, aPTT), blood type & cross‑match, electrolytes, BUN/creatinine, liver function tests.

Focused Diagnostic Tests

• Upper endoscopy (esophagogastroduodenoscopy, EGD) – performed within 24 hours of stabilization; allows direct visualization, diagnosis, and often therapeutic hemostasis (e.g., clipping, banding, injection).
• Contrast‑enhanced CT angiography – useful when endoscopy is unavailable, the patient is unstable, or when a vascular source such as an aorto‑esophageal fistula is suspected.
• Radionuclide bleeding scan (technetium‑99m labeled RBC scan) – detects active bleeding rates as low as 0.1 mL/min, but localization is less precise.
• Plain abdominal X‑ray – mainly to look for free air (perforation) or signs of severe gastric distension.

Risk Stratification

Scoring systems like the Glasgow-Blatchford Score (GBS) or the AIMS65 score help predict the need for intervention, transfusion, or ICU admission. A GBS ≥ 12 or an AIMS65 ≥ 3 typically indicates a high risk of mortality and guides aggressive management [2].

Treatment Options

Treatment is a blend of emergency stabilization, controlling the bleed, and addressing the underlying cause.

Immediate Medical Management

• Fluid resuscitation – isotonic crystalloids (normal saline or lactated Ringer’s) 1–2 L boluses, titrated to maintain MAP ≥ 65 mmHg.
• Blood transfusion – transfuse packed red blood cells to keep hemoglobin ≥ 7–8 g/dL in most patients; higher targets (≥ 9 g/dL) for those with cardiovascular disease.
• Proton pump inhibitors (PPIs) – high‑dose IV pantoprazole 80 mg bolus then 8 mg/h infusion; reduces gastric acidity and promotes clot stability.
• Octreotide (somatostatin analog) – 50 µg IV bolus followed by 50 µg/h infusion for suspected variceal bleeding; decreases portal pressure.
• Correction of coagulopathy – vitamin K, fresh frozen plasma, or Prothrombin Complex Concentrate (PCC) if INR > 1.5; platelets if < 50 × 10⁹/L.
• Antibiotics – for cirrhotic patients with variceal bleeding (e.g., ceftriaxone 1 g IV daily) to prevent spontaneous bacterial peritonitis and improve survival [3].

Endoscopic Therapy (within 24 h)

During EGD, the endoscopist may use one or more of the following techniques:

• Thermal coagulation – heater probe or bipolar cautery to coagulate bleeding vessels.
• Injection therapy – epinephrine 1:10,000 solution to cause vasoconstriction.
• Clipping – metallic clips applied directly over a visible vessel or ulcer base.
• Band ligation – first‑line for esophageal varices; rubber bands strangulate the varix.
• Sclerotherapy – injection of a sclerosant into varices when banding is not feasible.

Radiologic and Surgical Options

• Trans‑arterial embolization (TAE) – interventional radiology technique to occlude bleeding arteries (e.g., gastroduodenal artery) when endoscopy fails.
• Balloon tamponade – Sengstaken or Minnesota tubes as a bridge to definitive therapy for uncontrolled variceal bleeding.
• Surgical intervention – subtotal gastrectomy, oversewing of a bleeding ulcer, or esophageal devascularization when endoscopic and radiologic measures are unsuccessful.

After‑care and Long‑Term Management

• Repeat endoscopy in 6–8 weeks to ensure ulcer healing.
• Eradication of Helicobacter pylori infection if present (triple therapy).
• Long‑term PPI therapy (once daily) for high‑risk ulcers.
• Beta‑blockers (e.g., propranolol) for variceal bleed prophylaxis in cirrhosis.
• Alcohol cessation, smoking cessation, and weight management to reduce ulcer recurrence.
• Regular surveillance endoscopy for patients with known Barrett’s esophagus or gastric cancer risk.

Prevention Tips

While not all massive bleeds can be prevented, many risk factors are modifiable:

• Avoid NSAIDs and aspirin unless prescribed; use acetaminophen for pain if appropriate.
• Limit alcohol intake – > 2 drinks/day for men, > 1 drink/day for women raises ulcer and variceal risk.
• Quit smoking – smoking impairs mucosal defense and delays ulcer healing.
• Manage liver disease – abstain from alcohol, maintain a low‑sodium diet, and adhere to antivirals for hepatitis B/C.
• Screen for H. pylori – test and treat; eradication reduces ulcer recurrence by up to 80 %.
• Take PPIs prophylactically if you have a history of ulcer disease and need chronic NSAID therapy.
• Maintain a balanced diet rich in fruits, vegetables, and fiber to support gastric mucosal health.
• Regular medical follow‑up for cirrhosis, coagulopathies, or known GI lesions.
• Use anticoagulants cautiously – have INR or anti‑Xa levels monitored regularly when on warfarin, dabigatran, or rivaroxaban.

Emergency Warning Signs